SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: bluejeans who wrote (19817)4/29/1998 9:05:00 PM
From: John Rowton  Respond to of 32384
 
I wish lgnd would either go up or down, this trading range is killing
me. Back down to the 12 area is a screaming trading buy as it will
be up to 15 within a few months. Just laying there.



To: bluejeans who wrote (19817)4/29/1998 9:37:00 PM
From: Flagrante Delictu  Read Replies (5) | Respond to of 32384
 
Bob, It was David Molowa of Bear Stearns. When asked what his favorites were , he mentioned LGND first, then VRTX, &, finally, VRUS.
The Pru analyst mentioned Medimmune & probably CNTO.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News